← Back to Search

Behavioural Intervention

Functional Electrical Stimulation Therapy for Spinal Cord Injury

N/A

Waitlist Available

Led By José Zariffa, PhD

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up muscle strength assessed at each of 30 therapy sessions (3-5 sessions per week).

Awards & highlights

Study Summary

This trial is testing a new diagnostic method to help predict which muscles will respond best to functional electrical stimulation therapy (FES-T). This will allow therapists to create personalized therapy plans, leading to more effective use of healthcare resources and improved outcomes.

Who is the study for?

This trial is for adults over 18 with a cervical spinal cord injury, who have arm or hand function issues. They must understand instructions, sit for an hour, attend all therapy and assessment sessions, and be at least six months post-injury.Check my eligibility

What is being tested?

The study tests if a diagnostic method can predict muscle response to Functional Electrical Stimulation Therapy (FES-T) in people with spinal injuries. It involves electrophysiological exams and tracking strength recovery over 30 sessions using machine learning.See study design

What are the potential side effects?

While the document doesn't list specific side effects of FES-T, common ones may include discomfort or skin irritation where electrodes are placed, muscle fatigue from repeated contractions, and possible muscle soreness after therapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ muscle strength assessed at each of 30 therapy sessions (3-5 sessions per week).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~muscle strength assessed at each of 30 therapy sessions (3-5 sessions per week).

This trial's timeline: 3 weeks for screening, Varies for treatment, and muscle strength assessed at each of 30 therapy sessions (3-5 sessions per week). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Muscle strength recovery profile

Secondary outcome measures

Surface electromyography signal features

Trial Design

1Treatment groups

Experimental Treatment

Group I: Functional electrical stimulation therapyExperimental Treatment1 Intervention

Participants will receive 30 sessions of upper limb functional electrical stimulation therapy. Sessions will be 1 hour in length and take place 3-5 times per week.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor

1,468 Previous Clinical Trials

484,509 Total Patients Enrolled

Wings for LifeOTHER

6 Previous Clinical Trials

843 Total Patients Enrolled

José Zariffa, PhDPrincipal InvestigatorUniversity Health Network, Toronto

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Approximately how many participants are enrolled in this research effort?

"Affirmative. According to information on clinicaltrials.gov, this research venture is currently enrolling individuals; the study was initially shared on July 20th of 2022 and last modified a day after that date. The trial requires 10 volunteers at one medical facility."

Answered by AI

Are recruitment efforts for this research still ongoing?

"Affirmative. Clinicaltrials.gov indicates that this clinical trial, which went live on July 20th 2022, is actively searching for participants. The study requires 10 individuals across one medical centre to take part in the research."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Prediction of Muscle Responsiveness to FES Therapy

2022. "Prediction of Muscle Responsiveness to FES Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05462925.